Muro 128 Ointment
NDC Package 24208-385-01

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Other Packages
    3. Frequently Asked Questions

Package Information

Muro 128 (sodium chloride) ointment is a medication used to treat dryness inside the nose (nasal passages). This formulation utilizes a ointment delivery system. Marketed by Bausch & Lomb Incorporated, this product is identified by NDC 24208-385 and is authorized under FDA application M018.

Identification & Billing

NDC Package Code
24208-385-01
Package Description
1 TUBE in 1 CARTON / 1 g in 1 TUBE
Product Code
24208-385
11-Digit Billing Format
24208038501
RxNorm Crosswalk

Clinical Specifications

Proprietary Name
Muro 128
Non-Proprietary Name
Sodium Chloride
Substance Name
Sodium Chloride
Dosage Form
Ointment - A semisolid3 dosage form, usually containing <20% water and volatiles5 and >50% hydrocarbons, waxes, or polyols as the vehicle. This dosage form is generally for external application to the skin or mucous membranes.
Administration Route
Ophthalmic - Administration to the external eye.
Active Ingredient(s)
SODIUM CHLORIDE 50 mg/g
Pharmacologic Class
Usage Information
This product is used to treat dryness inside the nose (nasal passages). It helps add moisture inside the nose to dissolve and soften thick or crusty mucus. In babies and young children with stuffy noses who cannot blow their noses, using this product helps to make the mucus easier to remove with a nasal bulb syringe. This helps relieve stuffiness and makes breathing easier. This product contains a purified gentle salt solution (also called saline or sodium chloride solution). It does not contain any medication.

Regulatory & Marketing

Labeler Name
Bausch & Lomb Incorporated
Product Type
Human Otc Drug
FDA Application #
M018
Marketing Category
OTC MONOGRAPH DRUG -
Start Marketing Date
01-01-2011
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
Yes

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (24208-385). Click a package code to view its specific billing and regulatory data.

24208-385-55
1 TUBE in 1 CARTON / 3.5 g in 1 TUBE
24208-385-56
2 TUBE in 1 CARTON / 3.5 g in 1 TUBE

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 24208-385-01 identifies a specific commercial package of 1 tube in 1 carton / 1 g in 1 tube of Muro 128, a human over the counter drug labeled by Bausch & Lomb Incorporated. This ointment is formulated for ophthalmic use and contains sodium chloride as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Bausch & Lomb Incorporated on January 01, 2011. The current certification is valid through December 31, 2026.

What are the primary indications for this medication?

This product is used to treat dryness inside the nose (nasal passages). It helps add moisture inside the nose to dissolve and soften thick or crusty mucus. In babies and young children with stuffy noses who cannot blow their noses, using this product helps to make the mucus easier to remove with a nasal bulb syringe. This helps relieve stuffiness and makes breathing easier. This product contains a purified gentle salt solution (also called saline or sodium chloride solution). It does not contain any medication.

How is this Bausch & Lomb Incorporated product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 24208038501. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
24208-385-01
11-Digit CMS (5-4-2)
24208-0385-01

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.